Prognosis
Trump Signs Order Seeking to Return Drug Production to U.S.
- Shortages of crucial medicines have emerged during pandemic
- Reliance on foreign manufacturers has been longstanding worry
Photographer: Andrey Rudakov/Bloomberg
This article is for subscribers only.
President Donald Trump signed an executive order that would encourage the production of certain drugs and medical supplies in the U.S. following shortages during the Covid-19 pandemic.
The order urges purchasers to buy American-made products and loosens federal drug-safety and environmental regulations that the administration says disadvantage domestic producers, among other measures.